118 related articles for article (PubMed ID: 7782167)
21. Investigation of the structural parameters involved in the mu and delta opioid receptor discrimination of linear enkephalin-related peptides.
Gacel G; Zajac JM; Delay-Goyet P; Daugé V; Roques BP
J Med Chem; 1988 Feb; 31(2):374-83. PubMed ID: 2828622
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides.
Tomatis R; Marastoni M; Balboni G; Guerrini R; Capasso A; Sorrentino L; Santagada V; Caliendo G; Lazarus LH; Salvadori S
J Med Chem; 1997 Aug; 40(18):2948-52. PubMed ID: 9288177
[TBL] [Abstract][Full Text] [Related]
23. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
24. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
[TBL] [Abstract][Full Text] [Related]
25. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
Mosberg HI; Heyl DL; Haaseth RC; Omnaas JR; Medzihradsky F; Smith CB
Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues.
Marastoni M; Salvadori S; Balboni G; Borea PA; Marzola G; Tomatis R
J Med Chem; 1987 Sep; 30(9):1538-42. PubMed ID: 2887656
[TBL] [Abstract][Full Text] [Related]
27. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
Porreca F; LoPresti D; Ward SJ
Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
[TBL] [Abstract][Full Text] [Related]
28. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites.
Erspamer V; Melchiorri P; Falconieri-Erspamer G; Negri L; Corsi R; Severini C; Barra D; Simmaco M; Kreil G
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5188-92. PubMed ID: 2544892
[TBL] [Abstract][Full Text] [Related]
29. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the opioid activity of a number of enkephalin and dermorphin analogs].
Chichenkov ON; Sumbatian NV; Riabtseva ON; Korshunova GA; Shorr VA
Farmakol Toksikol; 1988; 51(5):17-20. PubMed ID: 2850219
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
Schiller PW; Nguyen TM; Lemieux C; Maziak LA
J Med Chem; 1985 Dec; 28(12):1766-71. PubMed ID: 2999401
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine-iodination converts the delta-opioid peptide antagonist TIPP to an agonist.
Lee PH; Nguyen TM; Chung NN; Schiller PW; Chang KJ
Eur J Pharmacol; 1995 Jul; 280(2):211-4. PubMed ID: 7589188
[TBL] [Abstract][Full Text] [Related]
33. Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo.
Kramer TH; Shook JE; Kazmierski W; Ayres EA; Wire WS; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 May; 249(2):544-51. PubMed ID: 2566679
[TBL] [Abstract][Full Text] [Related]
34. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
[TBL] [Abstract][Full Text] [Related]
35. The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors.
Rogers H; Hayes AG; Birch PJ; Traynor JR; Lawrence AJ
J Pharm Pharmacol; 1990 May; 42(5):358-9. PubMed ID: 1976787
[TBL] [Abstract][Full Text] [Related]
36. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
[TBL] [Abstract][Full Text] [Related]
37. Receptor binding and biological activity of bivalent enkephalins.
Costa T; Wüster M; Herz A; Shimohigashi Y; Chen HC; Rodbard D
Biochem Pharmacol; 1985 Jan; 34(1):25-30. PubMed ID: 2981528
[TBL] [Abstract][Full Text] [Related]
38. Para-substituted Phe3 deltorphin analogues: enhanced selectivity of halogenated derivatives for delta opioid receptor sites.
Salvadori S; Bianchi C; Lazarus LH; Scaranari V; Attila M; Tomatis R
J Med Chem; 1992 Dec; 35(25):4651-7. PubMed ID: 1335080
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides.
Marastoni M; Salvadori S; Balboni G; Scaranari V; Borea PA; Tomatis A
Arzneimittelforschung; 1995 Feb; 45(2):116-9. PubMed ID: 7710429
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
